Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, anticancer evaluation, in silico docking and ADMET analysis of novel indole-based thalidomide analogs as promising immunomodulatory agents
Mohamed Ayman El‐Zahabi, Hazem Elkady, Helmy Sakr, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 24, pp. 15106-15123
Closed Access | Times Cited: 13

Showing 13 citing articles:

Anti-angiogenic and anti-oxidant effects of 2-NTI indole derivative vs. suramin in ex vivo, in vivo, and in vitro studies
Bayan Jamal Khaleel, H. Salman, Haitham Mahmood Kadhim, et al.
Cytotechnology (2025) Vol. 77, Iss. 1
Closed Access | Times Cited: 1
New quinazoline sulfonamide derivatives as potential anticancer agents: Identifying a promising hit with dual EGFR/VEGFR-2 inhibitory and radiosensitizing activity
Mostafa M. Ghorab, Aiten M. Soliman, Khaled El‐Adl, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106791-106791
Closed Access | Times Cited: 23
Novel promising benzoxazole/benzothiazole‐derived immunomodulatory agents: Design, synthesis, anticancer evaluation, and in silico ADMET analysis
Hazem Elkady, Khaled El‐Adl, Helmy Sakr, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 9
Closed Access | Times Cited: 20
Pyrazolo[3,4-d]pyrimidine derivatives as EGFRT790M and VEGFR-2 dual TK inhibitors: Design, synthesis, molecular docking, ADMET profile and anticancer evaluations
Dina Adel, Khaled El‐Adl, Tamer Nasr, et al.
Journal of Molecular Structure (2023) Vol. 1291, pp. 136047-136047
Closed Access | Times Cited: 14
Anticancer evaluations of iodoquinazoline substituted with allyl and/or benzyl as dual inhibitors of EGFRWT and EGFRT790M: design, synthesis, ADMET and molecular docking
Ahmed K. B. Aljohani, Khaled El‐Adl, Basmah Almohaywi, et al.
RSC Advances (2024) Vol. 14, Iss. 12, pp. 7964-7980
Open Access | Times Cited: 3
Exploration of the VEGFR-2 inhibition activity of phthalazine derivatives: design, synthesis, cytotoxicity, ADMET, molecular docking and dynamic simulation
Hatem Hussein Bayoumi, Mohamed‐Kamal Ibrahim, Mohammed A. Dahab, et al.
RSC Advances (2024) Vol. 14, Iss. 30, pp. 21668-21681
Open Access | Times Cited: 2
Rationale, in silico docking, ADMET profile, design, synthesis and cytotoxicity evaluations of phthalazine derivatives as VEGFR-2 inhibitors and apoptosis inducers
Hatem Hussein Bayoumi, Mohamed‐Kamal Ibrahim, Mohammed A. Dahab, et al.
RSC Advances (2024) Vol. 14, Iss. 37, pp. 27110-27121
Open Access | Times Cited: 2
Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide Analogs
Reda R. Mabrouk, Abdallah E. Abdallah, Hazem A. Mahdy, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12416-12416
Open Access | Times Cited: 7
Rationale design and synthesis of new apoptotic thiadiazole derivatives targeting VEGFR-2: computational and in vitro studies
Walid E. Elgammal, Hazem Elkady, Hazem A. Mahdy, et al.
RSC Advances (2023) Vol. 13, Iss. 51, pp. 35853-35876
Open Access | Times Cited: 6
Design, synthesis and biological evaluation of newly triazolo-quinoxaline based potential immunomodulatory anticancer molecules
Maged Mohammed Saleh Al Ward, Abdallah E. Abdallah, Mohamed F. Zayed, et al.
Journal of Molecular Structure (2023) Vol. 1298, pp. 137041-137041
Closed Access | Times Cited: 5
Design, synthesis, docking, ADMET and anticancer evaluations of N-alkyl substituted iodoquinazoline derivatives as dual VEGFR-2 and EGFR inhibitors
Marwa Alsulaimany, Khaled El‐Adl, Ahmed K. B. Aljohani, et al.
RSC Advances (2023) Vol. 13, Iss. 51, pp. 36301-36321
Open Access | Times Cited: 5
Exploration of cytotoxicity of iodoquinazoline derivatives as inhibitors of both VEGFR‐2 and EGFRT790M: Molecular docking, ADMET, design, and syntheses
Marwa Alsulaimany, Sanadelaslam S. A. El‐Hddad, Zuhir S. M. Akrim, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 11
Open Access | Times Cited: 1
New immunomodulatory anticancer quinazolinone-based thalidomide analogs: design, synthesis and biological evaluation
Maged Mohammed Saleh Al Ward, Abdallah E. Abdallah, Mohamed F. Zayed, et al.
Future Medicinal Chemistry (2024), pp. 1-11
Open Access | Times Cited: 1
Page 1

Scroll to top